相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
M. S. Kim et al.
BRITISH JOURNAL OF CANCER (2008)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung
Donatella Malanga et al.
CELL CYCLE (2008)
Pharmacodynamic markers of perifosine efficacy
Bryan T. Hennessy et al.
CLINICAL CANCER RESEARCH (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms
John Brognard et al.
MOLECULAR CELL (2007)
High-throughput oncogene mutation profiling in human cancer
Roman K. Thomas et al.
NATURE GENETICS (2007)
MC1R germline variants confer risk for BRAF-mutant melanoma
Maria Teresa Landi et al.
SCIENCE (2006)
PI3-kinase subunits are infrequent somatic targets in melanoma
John A. Curtin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Mutations of PIK3CA are rare in cutaneous melanoma
K Omholt et al.
MELANOMA RESEARCH (2006)
Genetic alterations in signaling pathways in melanoma
FG Haluska et al.
CLINICAL CANCER RESEARCH (2006)
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
Vikas K. Goel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition
HY Irie et al.
JOURNAL OF CELL BIOLOGY (2005)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Detection of B-RAF and N-RAS mutations in human melanoma
JS Goydos et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion
JN Hutchinson et al.
CANCER RESEARCH (2004)
PI 3-kinase, Akt and cell survival
J Downward
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Medical progress - Management of cutaneous melanoma
H Tsao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Deregulated Akt3 activity promotes development of malignant melanoma
JM Stahl et al.
CANCER RESEARCH (2004)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Absence of mutations in the pleckstrin homology (PH) domain of protein kinase B (PKB/Akt) in malignant melanoma
V Waldmann et al.
MELANOMA RESEARCH (2002)
Mutations of the activation-associated phosphorylation sites at codons 308 and 473 of protein kinase B are absent in human melanoma
V Waldmann et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2001)
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
XP Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
